Annual Current Liabilities
$38.93 M
+$13.77 M+54.73%
December 31, 2023
Summary
- As of February 7, 2025, SEEL annual total current liabilities is $38.93 million, with the most recent change of +$13.77 million (+54.73%) on December 31, 2023.
- During the last 3 years, SEEL annual current liabilities has risen by +$31.50 million (+424.00%).
- SEEL annual current liabilities is now at all-time high.
Performance
SEEL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$30.51 M
-$6.20 M-16.89%
June 30, 2024
Summary
- As of February 7, 2025, SEEL quarterly total current liabilities is $30.51 million, with the most recent change of -$6.20 million (-16.89%) on June 30, 2024.
- Over the past year, SEEL quarterly current liabilities has dropped by -$4.81 million (-13.62%).
- SEEL quarterly current liabilities is now -45.62% below its all-time high of $56.11 million, reached on June 30, 2023.
Performance
SEEL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SEEL Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +54.7% | -13.6% |
3 y3 years | +424.0% | +21.3% |
5 y5 years | +3221.5% | +471.4% |
SEEL Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +369.8% | -45.6% | +268.2% |
5 y | 5-year | at high | +424.0% | -45.6% | +974.8% |
alltime | all time | at high | +5461.1% | -45.6% | +9489.6% |
Seelos Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $30.51 M(-16.9%) |
Mar 2024 | - | $36.72 M(-5.7%) |
Dec 2023 | $38.93 M(+54.7%) | $38.93 M(+10.2%) |
Sep 2023 | - | $35.33 M(-37.0%) |
Jun 2023 | - | $56.11 M(+43.1%) |
Mar 2023 | - | $39.20 M(+55.8%) |
Dec 2022 | $25.16 M(+203.6%) | $25.16 M(+14.9%) |
Sep 2022 | - | $21.89 M(+49.6%) |
Jun 2022 | - | $14.63 M(+44.4%) |
Mar 2022 | - | $10.13 M(+22.2%) |
Dec 2021 | $8.29 M(+11.5%) | $8.29 M(+3.1%) |
Sep 2021 | - | $8.03 M(+5.8%) |
Jun 2021 | - | $7.59 M(-43.1%) |
Mar 2021 | - | $13.34 M(+79.5%) |
Dec 2020 | $7.43 M(-31.1%) | $7.43 M(+161.7%) |
Sep 2020 | - | $2.84 M(-23.4%) |
Jun 2020 | - | $3.71 M(-48.6%) |
Mar 2020 | - | $7.21 M(-33.1%) |
Dec 2019 | $10.78 M(+819.6%) | $10.78 M(+94.6%) |
Sep 2019 | - | $5.54 M(+3.7%) |
Jun 2019 | - | $5.34 M(-42.6%) |
Mar 2019 | - | $9.31 M(+694.1%) |
Dec 2018 | $1.17 M(-26.0%) | $1.17 M(-17.8%) |
Sep 2018 | - | $1.43 M(-25.1%) |
Jun 2018 | - | $1.90 M(+12.6%) |
Mar 2018 | - | $1.69 M(+6.8%) |
Dec 2017 | $1.58 M(-86.0%) | $1.58 M(-12.7%) |
Sep 2017 | - | $1.81 M(-1.6%) |
Jun 2017 | - | $1.84 M(-28.8%) |
Mar 2017 | - | $2.59 M(-77.1%) |
Dec 2016 | $11.29 M(-28.0%) | $11.29 M(-10.4%) |
Sep 2016 | - | $12.61 M(-5.0%) |
Jun 2016 | - | $13.27 M(+0.1%) |
Mar 2016 | - | $13.25 M(-15.5%) |
Dec 2015 | $15.68 M(+127.1%) | $15.68 M(+128.8%) |
Sep 2015 | - | $6.86 M(+37.8%) |
Jun 2015 | - | $4.97 M(-30.5%) |
Mar 2015 | - | $7.16 M(+3.6%) |
Dec 2014 | $6.91 M(-41.3%) | $6.91 M(+8.1%) |
Sep 2014 | - | $6.39 M(-8.4%) |
Jun 2014 | - | $6.97 M(-52.2%) |
Mar 2014 | - | $14.58 M(+24.0%) |
Dec 2013 | $11.76 M(+9.2%) | $11.76 M(+40.0%) |
Sep 2013 | - | $8.40 M(-23.7%) |
Jun 2013 | - | $11.00 M(+8.2%) |
Mar 2013 | - | $10.17 M(-5.5%) |
Dec 2012 | $10.77 M(+7.4%) | $10.77 M(-27.2%) |
Sep 2012 | - | $14.78 M(+35.9%) |
Jun 2012 | - | $10.87 M(+9.9%) |
Mar 2012 | - | $9.89 M(-1.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $10.02 M(+332.6%) | $10.02 M(+247.0%) |
Sep 2011 | - | $2.89 M(-21.5%) |
Jun 2011 | - | $3.68 M(+44.9%) |
Mar 2011 | - | $2.54 M(+9.6%) |
Dec 2010 | $2.32 M(-83.7%) | $2.32 M(+24.0%) |
Sep 2010 | - | $1.87 M(-20.7%) |
Jun 2010 | - | $2.35 M(-80.4%) |
Mar 2010 | - | $12.01 M(-15.3%) |
Dec 2009 | $14.17 M(+912.6%) | $14.17 M(+3026.4%) |
Sep 2009 | - | $453.40 K(-55.5%) |
Jun 2009 | - | $1.02 M(+6.0%) |
Mar 2009 | - | $962.50 K(-31.2%) |
Dec 2008 | $1.40 M(-39.9%) | $1.40 M(-44.2%) |
Sep 2008 | - | $2.51 M(+22.6%) |
Jun 2008 | - | $2.05 M(-11.8%) |
Mar 2008 | - | $2.32 M(-0.3%) |
Dec 2007 | $2.33 M(-68.4%) | $2.33 M(-35.8%) |
Sep 2007 | - | $3.63 M(-2.1%) |
Jun 2007 | - | $3.71 M(-48.5%) |
Mar 2007 | - | $7.19 M(-2.4%) |
Dec 2006 | $7.37 M(-6.7%) | $7.37 M(-16.4%) |
Sep 2006 | - | $8.82 M(-1.1%) |
Jun 2006 | - | $8.92 M(+31.8%) |
Mar 2006 | - | $6.77 M(-14.3%) |
Dec 2005 | $7.90 M(+281.8%) | $7.90 M(+46.1%) |
Sep 2005 | - | $5.41 M(+186.7%) |
Jun 2005 | - | $1.89 M(+2.0%) |
Mar 2005 | - | $1.85 M(-10.7%) |
Dec 2004 | $2.07 M(-32.7%) | $2.07 M(-14.4%) |
Sep 2004 | - | $2.42 M(-31.0%) |
Jun 2004 | - | $3.50 M(+11.8%) |
Mar 2004 | - | $3.13 M(+1.8%) |
Dec 2003 | $3.07 M(-43.9%) | $3.07 M(+58.3%) |
Sep 2003 | - | $1.94 M(-27.8%) |
Jun 2003 | - | $2.69 M(-50.3%) |
Mar 2003 | - | $5.41 M(-1.4%) |
Dec 2002 | $5.48 M(+120.9%) | $5.48 M(+198.4%) |
Sep 2002 | - | $1.84 M(-24.5%) |
Jun 2002 | - | $2.43 M(+20.2%) |
Mar 2002 | - | $2.03 M(-18.4%) |
Dec 2001 | $2.48 M(+99.3%) | $2.48 M(+82.5%) |
Sep 2001 | - | $1.36 M(+23.1%) |
Jun 2001 | - | $1.11 M(-14.1%) |
Mar 2001 | - | $1.29 M(+3.3%) |
Dec 2000 | $1.25 M(+77.9%) | $1.25 M(+159.7%) |
Sep 2000 | - | $479.60 K(+50.7%) |
Jun 2000 | - | $318.20 K(-24.7%) |
Mar 2000 | - | $422.80 K |
Dec 1999 | $700.00 K(-78.5%) | - |
Dec 1997 | $3.26 M | - |
FAQ
- What is Seelos Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Seelos Therapeutics?
- What is Seelos Therapeutics annual current liabilities year-on-year change?
- What is Seelos Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly current liabilities year-on-year change?
What is Seelos Therapeutics annual total current liabilities?
The current annual current liabilities of SEEL is $38.93 M
What is the all time high annual current liabilities for Seelos Therapeutics?
Seelos Therapeutics all-time high annual total current liabilities is $38.93 M
What is Seelos Therapeutics annual current liabilities year-on-year change?
Over the past year, SEEL annual total current liabilities has changed by +$13.77 M (+54.73%)
What is Seelos Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SEEL is $30.51 M
What is the all time high quarterly current liabilities for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly total current liabilities is $56.11 M
What is Seelos Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SEEL quarterly total current liabilities has changed by -$4.81 M (-13.62%)